2022-09-27T13:17:36-05:00 2021-12-31 411431613 BERGANKDV LTD 2451 OAKDALE BLVD - STE 204 CORALVILLE IA 52241 990 2021-01-01 205239366 JOHN PAUL II MEDICAL RESEARCH INSTITUTE JOHN 3196887367 2500 CROSSPARK RD W230 CORALVILLE IA 52241 JAY KAMATH PRESIDENT 3196887367 2022-08-29 1 JAY KAMATH 999009999 BRUCE GUITHER CPA P00069444 3193543000 2022-08-29 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z JAY KAMATH 2500 CROSSPARK RD W230 CORALVILLE IA 52241 776190 0 X WWW.JP2MRI.ORG X 2006 IA ADVOCATES FOR MEDICAL RESEARCH THAT RECOGNIZES THE DIGNITIY OF HUMAN LIFE FROM THE MOMENT OF CONCEPTION TO NATURAL DEATH AND ADDRESS UNMET MEDICAL NEEDS. 8 5 7 6 0 0 253162 775994 8036 0 86 196 0 0 261284 776190 0 0 0 0 141645 136418 185 142 1476 150809 228512 292639 365072 -31355 411118 131912 513407 152822 123199 -20910 390208 X THE JOHN PAUL II MEDICAL RESEARCH INSTITUTE (JP2MRI) SEEKS TO FIND CURES AND THERAPIES EXCLUSIVELY USING A VARIETY OF ADULT STEM CELLS AND INDUCED PLURIPOTENT STEM CELLS. THE INSTITUTE DOES NOT ENGAGE IN EMBRYONIC STEM CELL RESEARCH OF ANY KIND. JP2MRI DEVELOPS PRECLINICAL RESEARCH TECHNOLOGIES THAT WILL BROADLY ADVANCE DRUG DISCOVERY AND REGENERATIVE MEDICINE FOR MANY DISEASES. IN ADDITION, THE INSTITUTE WILL ENGAGE IN EDUCATIONAL OUTREACH TO INCREASE THE NUMBER OF SCIENTISTS AND FUTURE MEDICAL PRACTITIONERS WHO WILL WORK WITH ADULT STEM CELLS, ALWAYS WITH AN EMPHASIS ON MEDICAL BIOETHICS THAT IS CONSISTENT WITH THE DIGNITY OF HUMAN LIFE. 0 0 169294 TO DEVELOP A COLLABORATIVE BASIC AND CLINICAL RESEARCH PROGRAM IN OUR FOUR CORE RESEARCH AREAS: CANCER, NEURODEGENERATIVE DISEASES, RARE DISEASES, AND ADULT STEM CELL THERAPIES. IN 2021, DUE TO AN OVERWHELMING REQUEST FROM THE INSTITUTE'S SUPPORTERS SEEKING AN ETHICAL ALTERNATIVE TO THE CORONAVIRUS VACCINES ON THE MARKET, JP2MRI DEVOTED SOME OF OUR RESEARCH EFFORTS INTO DEVELOPING A SAFER AND MORE ROBUST CORONAVIRUS VACCINE UTILIZING A TRADITIONAL NON-MRNA BASED APPROACH THAT WAS FREE OF ABORTED FETAL TISSUE IN DEVELOPMENT AND TESTING. THIS EFFORT HAS RESULTED IN A PIPELINE OF ATTENUATED VACCINE CANDIDATES THAT ARE READY FOR FURTHER TESTING. JP2MRI HAS A STRONG TRACK RECORD OF ADVANCING THERAPEUTICS FOR A VARIETY OF UNMET MEDICAL NEEDS AT A COST THAT IS MUCH LOWER THAN TYPICALLY CHARGED BY INDUSTRY, GOVERNMENT OR ACADEMIA. THE INSTITUTE'S CORE RESEARCH PRIORITIES INCLUDE NEURODEGENERATIVE DISEASES, RARE DISEASES, CANCER AND REGENERATIVE MEDICINE FOR UNMET CHRONIC DISEASES. 169294 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 7 1 0 0 0 0 0 0 0 0 0 0 0 0 X 8 5 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 0 0 0 X X JAY KAMATH 3196887367 2500 CROSSPARK RD W230 IOWA CITY IA 52241 JAY KAMATH PRESIDENT 5.00 X X 69175 0 1695 DR ALAN MOY VICE PRESIDENT 5.00 X X 25000 0 0 KATHERINE ARBUCKLE TREASURER 0.25 X X 0 0 0 ANDY MILAM SECRETARY 0.25 X X 0 0 0 JEANNE MOY DIRECTOR 0.25 X 0 0 0 ISAAC DOUCETTE DIRECTOR 0.25 X 0 0 0 DR JAMES BECKER DIRECTOR 0.25 X 0 0 0 DR MARTIN BEDNAR DIRECTOR 0.25 X 0 0 0 94175 0 1695 0 0 0 0 0 12700 763294 775994 196 196 776190 0 0 196 95871 25000 70871 22103 22103 10411 10411 8033 2263 5770 7266 7266 5155 5155 142 142 1334 1334 80377 952 79425 37260 37260 1091 1091 2192 2192 1000 1000 2160 2160 RESEARCH & DEVELOPMENT 79227 79227 MISCELLANEOUS 5071 5071 REIMBURSEMENT 3340 3340 TELEPHONE 2466 2466 573 398 175 365072 169294 194302 1476 93260 475055 38652 34352 143566 139566 0 4000 131912 513407 20396 7000 3818 119726 112381 12700 0 152822 123199 X 0 0 0 0 -20910 390208 -20910 390208 131912 513407 411118 0 X 0 0 0 X 161223 128957 279177 253162 775994 1598513 161223 128957 279177 253162 775994 1598513 200072 1398441 53 69 27 86 196 431 3398 1500 8036 12934 1611878 0.86760 0.98770 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 143566 139566 4000 4000 DR ALAN MOY CURRENT OFFICER OPERATING EXPENSES X 3818 3818 0 1 1 3818 FORM 990, PART VI, SECTION A, LINE 2 ALAN MOY AND JEANNE MOY HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE 990 WAS DISTRIBUTED TO MEMBERS OF THE GOVERNING BODY BEFORE FILING, AND MEMBERS WERE INSTRUCTED TO REVIEW THE FORM AND PROVIDE FEEDBACK, IF ANY. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS ARE REQUIRED TO SUBMIT ANNUAL SURVEYS DISCLOSING ANY CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.